Showing 2 posts of 2 posts found.
GSK has set out plans to boost its flagging performance with the launch of up to 20 new drugs by …
Pfizer had a takeover approach rejected by fellow pharma giant GlaxoSmithKline, before turning its attentions to Allergan, it has emerged. …
NanoSomiX and Beckman Coulter Diagnostics collaborate on blood tests for neurodegenerative diseases
EMA selects TrialAssure anonymisation platform for clinical trial documents
Researchers develop new antifungal compounds with improved safety profile
Lonza and Engitix partner to develop next-generation antibody-drug conjugates
Simris Group appoints Tiffany J Vora as Strategic Advisor